New Key Statistics Module, Z-Score and F-Score
OTCPK:BGLAF Key Ratios
| Market Cap $ M | 1,236.95 |
| Enterprise Value $ M | 1,189.87 |
| P/E(ttm) | 33.79 |
| PE Ratio without NRI | 33.79 |
| Forward PE Ratio | 28.38 |
| Price/Book | 10.65 |
| Price/Sales | 7.42 |
| Price/Free Cash Flow | 39.12 |
| Price/Owner Earnings | 53.53 |
| Payout Ratio % | 0.47 |
| Revenue (TTM) $ M | 168.00 |
| EPS (TTM) $ | 0.36 |
| Beneish M-Score | -2.17 |
| 10-y EBITDA Growth Rate % | 8.60 |
| 5-y EBITDA Growth Rate % | 12.00 |
| y-y EBITDA Growth Rate % | 3.70 |
| EV-to-EBIT | 25.05 |
| EV-to-EBITDA | 23.76 |
| PEG | 2.82 |
| Shares Outstanding M | 101.16 |
| Net Margin (%) | 21.97 |
| Operating Margin % | 27.85 |
| Pre-tax Margin (%) | 28.12 |
| Quick Ratio | 4.44 |
| Current Ratio | 4.44 |
| ROA % (ttm) | 23.00 |
| ROE % (ttm) | 28.04 |
| ROIC % (ttm) | 42.86 |
| Dividend Yield % | 1.51 |
| Altman Z-Score | 32.87 |
BGLAF Number of Guru Trades
BGLAF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BGLAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BGLAF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioGaia AB Insider Transactions
No Available Data
News about OTCPK:BGLAF
Total 0- 1